INTELLIGENT BIO SOLUTIONS INC. - INBS

Sector: Healthcare · Industry: Surgical & Medical Instruments & Apparatus
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q3 2025 · Q2 2025
Value (USD)
Total reported value ($000)
$1.375M
QoQ value delta ($000)
+$162K (+13.36%)
Implied price effect (QoQ)
-40.73%
Shares
Total shares
1,353,411
QoQ shares delta
+645,787 (+91.26%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (INBS)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q3 2025)

Top 25 only Full list
Early Q2 2026 data: only 8 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
Alyeska Investment Group, L.P. 686 673,492 0.0%
ADAR1 Capital Management, LLC 434 426,433 0.04%
VANGUARD GROUP INC 99 97,686 0.0%
GEODE CAPITAL MANAGEMENT, LLC 60 58,873 0.0%
Warberg Asset Management LLC 45 44,693 0.01%
LPL Financial LLC 25 25,000 0.0%
GOLDMAN SACHS GROUP INC 13 12,830 0.0%
CITIGROUP INC 9 9,349 0.0%
NBC SECURITIES, INC. 2 2,641 0.0%
CURIO WEALTH, LLC 2 2,000 0.0%
BANK OF AMERICA CORP /DE/ 0 64 0.0%
NATIONAL BANK OF CANADA /FI/ 0 350 0.0%